.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Green Mantis Labs concentrated entirely in Tincture & Sublingual with a 100.0% category share, while the month-over-month change within this line declined by 46.48% and the brand held rank 11 in New York. Although year-over-year data is unavailable for the category, the single-line focus paired with a double-digit MoM contraction and a mid-teen rank position implies a reliance on depth over breadth that is currently not converting into higher placement.
With all sales anchored in Tincture & Sublingual at a $40.97 average price and a 46.48% MoM pullback in May 2026, the positioning skews toward a niche play that trades reach for specialization; holding rank 11 in New York under these conditions suggests limited buffer against demand shocks and price sensitivity. The implication is that without a second category to absorb volatility, a single large monthly swing can suppress rank progress by multiple positions, so near-term stability likely depends on moderating the MoM variance within Tincture & Sublingual or selectively adding a category that can capture at least a mid-single-digit share.
Competitive Landscape
Green Mantis Labs is ranked #11 in NY Tincture & Sublingual in May 2026, improving 18 positions from #29 in February 2026 and sitting two spots below its peak of #9 reached in April 2026; that trajectory contrasts with Ayrloom holding #1 with a 22.5% YoY sales increase while Green Mantis Labs slipped two ranks from #9 to #11 month over month, and diverges from Mfny (Marijuana Farms New York) which fell from a YoY rank of #3 to #4 alongside a 34.6% YoY sales decline. Compared with Head & Heal steady at #2 despite a 13.0% YoY sales contraction and Veterans Choice Creations (VCC) climbing from #4 to #3 on 14.0% YoY growth, Green Mantis Labs’ rapid three-month ascent paired with a one-month pullback implies a brand moving into the tier just outside the top 10 but needing sustained share capture to convert short-term gains into a stable top-10 position.
Notable Products
The steepest movement in May 2026 came from CBD/THC 1:1 Citrus Tincture (1000mg CBD, 1000mg THC), which fell 54.1% month over month while holding rank 1, and CBN/THC 2:1 Sleep Blueberry Tincture (400mg CBN, 200mg THC) declined 74.5% at rank 4. In contrast, CBN/THC 1:2 Sleep Blueberry Tincture (300mg CBN, 600mg THC) grew 43.3% but remained at rank 3 behind Watermelon Tincture (1000mg THC, 60ml), which dropped 36.6% at rank 2. All top-4 SKUs sit within Tincture & Sublingual, concentrating category exposure as the leading SKU’s dollar sales of $9,580 coexist with double-digit contraction in three of four positions. The pattern implies dependence on a single category with volatile month-to-month swings, suggesting the commercial direction needs either SKU-level mix rebalancing or new-category entries to stabilize share.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
